Mural Oncology Statistics

Total Valuation

Mural Oncology has a market cap or net worth of $42.65 million. The enterprise value is -$58.24 million.

Market Cap	42.65M
Enterprise Value	-58.24M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Mural Oncology has 17.27 million shares outstanding. The number of shares has increased by 1.99% in one year.

Current Share Class	17.27M
Shares Outstanding	17.27M
Shares Change (YoY)	+1.99%
Shares Change (QoQ)	+0.58%
Owned by Insiders (%)	1.51%
Owned by Institutions (%)	26.53%
Float	11.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.40
P/TBV Ratio	0.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.08, with a Debt / Equity ratio of 0.06.

Current Ratio	5.08
Quick Ratio	4.65
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-74.16

Financial Efficiency

Return on equity (ROE) is -76.27% and return on invested capital (ROIC) is -47.72%.

Return on Equity (ROE)	-76.27%
Return on Assets (ROA)	-43.80%
Return on Invested Capital (ROIC)	-47.72%
Return on Capital Employed (ROCE)	-127.25%
Revenue Per Employee	n/a
Profits Per Employee	-$1.13M
Employee Count	116
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-25.15%
50-Day Moving Average	2.46
200-Day Moving Average	3.20
Relative Strength Index (RSI)	43.03
Average Volume (20 Days)	103,080

Short Selling Information

The latest short interest is 341,869, so 1.98% of the outstanding shares have been sold short.

Short Interest	341,869
Short Previous Month	657,864
Short % of Shares Out	1.98%
Short % of Float	3.03%
Short Ratio (days to cover)	1.54

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-138.61M
Pretax Income	n/a
Net Income	-130.73M
EBITDA	-135.10M
EBIT	-138.61M
Earnings Per Share (EPS)	-$7.67

Full Income Statement

Balance Sheet

The company has $107.68 million in cash and $6.78 million in debt, giving a net cash position of $100.90 million or $5.84 per share.

Cash & Cash Equivalents	107.68M
Total Debt	6.78M
Net Cash	100.90M
Net Cash Per Share	$5.84
Equity (Book Value)	107.89M
Book Value Per Share	6.25
Working Capital	94.50M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$128.01 million and capital expenditures -$47,000, giving a free cash flow of -$128.05 million.

Operating Cash Flow	-128.01M
Capital Expenditures	-47,000
Free Cash Flow	-128.05M
FCF Per Share	-$7.42

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mural Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.99%
Shareholder Yield	-1.99%
Earnings Yield	-306.50%
FCF Yield	-300.21%

Analyst Forecast

The average price target for Mural Oncology is $13.00, which is 426.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	426.32%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1